// App-Quantinova.ai

: A case of severe hypercalcaemia secondary to primary hyperparathyroidism responding to steroids

Researchers

Presenter

  • Susan Mathew

Principal Investigators

  • Tracey Ellis

  • Edward Jude

Medical Centers

  • Tameside and Glossop Integrated Care NHS Foundation Trust, United Kingdom

  • University of Manchester, Manchester, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

  • Oncology (ONC)

  • Infectious Diseases (ID)

  • Autoimmune (AI)

  • Dermatology

  • Endocrine/metabolic Diseases (ME)

Disease

  • Primary hyperparathyroidism

  • Parathyroid carcinoma

  • Vitamin D deficiency

  • Parathyroid adenoma

  • Hypercalcaemia

  • Schizophrenia

  • Solid malignancies

  • Psoriasis

  • Multiple Myeloma

  • Coronavirus disease

Biomarkers

  • Parathyroid Hormone

Drug/Treatment

  • Zolendronic acid

  • Hydrocortisone

  • Prednisolone

  • Calcitonin

  • cholecalciferol

  • Cinacalcet hydrochloride

  • Ergocalciferol

  • MK8970

  • sestamibi

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved